ロード中...

Brain metastases in ALK-positive NSCLC – time to adjust current treatment algorithms

The progress in molecular biology has revolutionized systemic treatment of advanced non-small-cell lung cancer (NSCLC) from conventional chemotherapy to a treatment stratified by histology and genetic aberrations. Tumors harboring a translocation of the anaplastic-lymphoma-kinase (ALK) gene constitu...

詳細記述

保存先:
書誌詳細
出版年:Oncotarget
主要な著者: Griesinger, Frank, Roeper, Julia, Pöttgen, Christoph, Willborn, Kay C., Eberhardt, Wilfried E.E.
フォーマット: Artigo
言語:Inglês
出版事項: Impact Journals LLC 2018
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6205553/
https://ncbi.nlm.nih.gov/pubmed/30416687
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26073
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!